Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Spontaneous bacterial peritonitis.

Todd A Sheer1, Bruce A Runyon

  • 1Department of Internal Medicine, Division of Gastroenterology, Naval Medical Center San Diego, San Diego, Calif. 92134, USA. tasheer@nmcsd.med.navy.mil

Digestive Diseases (Basel, Switzerland)
|May 28, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical features of pseudocirrhosis in metastatic breast cancer.

Breast cancer research and treatment·2019
Same author

Treatment of Patients with Cirrhosis.

The New England journal of medicine·2017
Same author

Treatment of Patients with Cirrhosis.

The New England journal of medicine·2016
Same author

Defining a Patient Population With Cirrhosis: An Automated Algorithm With Natural Language Processing.

Journal of clinical gastroenterology·2016
Same author

Rapid Resolution of Hepatitis C Virus-Associated Cryoglobulin Rash With Use of Direct-Acting Antivirals.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2015
Same author

Spleen size in cirrhosis of different etiologies.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2015
Same journal

Pancreatitis in Familial Dysautonomia Patients.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Treatment outcomes with empirical Clarithromycin-based triple therapy for Helicobacter pylori in Zambia, sub-Saharan Africa.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Endoscopic submucosal dissection-associated bacteremia: proper antibiotic management.

Digestive diseases (Basel, Switzerland)·2026
Same journal

The investigation and treatment of Helicobacter pylori for the prevention of gastric cancer: A narrative review and assessment of management approaches.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Analysis of Helicobacter pylori resistance and its trends in Chongqing: A 10-year retrospective study.

Digestive diseases (Basel, Switzerland)·2026
Same journal

Early-onset colorectal cancer in Australia: environmental, microbial, and policy implications.

Digestive diseases (Basel, Switzerland)·2026
See all related articles

Spontaneous bacterial peritonitis (SBP) is a serious infection in cirrhosis patients. Early diagnosis via paracentesis and prompt antibiotic treatment, like cefotaxime, significantly reduces mortality.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Spontaneous bacterial peritonitis (SBP) is a common complication in patients with decompensated cirrhosis and ascites.
  • It involves bacterial translocation from the gut into the ascitic fluid.
  • SBP presents with diverse symptoms, necessitating a high index of suspicion.

Purpose of the Study:

  • To outline the diagnostic criteria and management strategies for spontaneous bacterial peritonitis.
  • To emphasize the importance of early detection and appropriate antibiotic therapy.

Main Methods:

  • Diagnostic paracentesis to analyze ascitic fluid for polymorphonuclear cell count and cultures.
  • Biochemical analysis of ascitic fluid (protein, LDH, glucose) to differentiate SBP from secondary peritonitis.

Related Experiment Videos

  • Empirical antibiotic therapy initiated promptly upon suspicion of SBP.

    • Main Results:

    • Ascitic fluid polymorphonuclear cell count is the most sensitive diagnostic marker.
    • Cefotaxime demonstrates excellent efficacy and safety for empirical treatment of SBP.
    • Early detection and treatment have led to a significant decline in SBP-related mortality.

    Conclusions:

    • Prompt diagnosis using paracentesis and initiation of empirical antibiotic therapy are crucial for managing SBP.
    • Cefotaxime is a highly effective and safe treatment option.
    • Improved therapeutic approaches have dramatically reduced mortality rates associated with SBP.